GFAP and Alzheimer disease: This early elevation likely reflects astrocytic responses to amyloid accumulation and compromised blood–brain barrier integrity, consistent with the neuropathological findings of increased GFAP expression around amyloid plaques and reactive astrocytosis observed in prodromal AD.